Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Capital Employed (2021 - 2023)

Historic Return on Capital Employed for Terns Pharmaceuticals (TERN) over the last 3 years, with Q3 2023 value amounting to 0.32%.

  • Terns Pharmaceuticals' Return on Capital Employed rose 500.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.28% for FY2022, which is 1200.0% up from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Return on Capital Employed stood at 0.32%, which was up 500.0% from 0.26% recorded in Q2 2023.
  • Terns Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.22% for Q2 2021, and its period low was 0.37% during Q2 2022.
  • Moreover, its 3-year median value for Return on Capital Employed was 0.3% (2021), whereas its average is 0.29%.
  • Per our database at Business Quant, Terns Pharmaceuticals' Return on Capital Employed plummeted by -1500bps in 2022 and then soared by 1100bps in 2023.
  • Quarter analysis of 3 years shows Terns Pharmaceuticals' Return on Capital Employed stood at 0.3% in 2021, then rose by 10bps to 0.27% in 2022, then fell by -19bps to 0.32% in 2023.
  • Its last three reported values are 0.32% in Q3 2023, 0.26% for Q2 2023, and 0.25% during Q1 2023.